Clinical Trial Update: Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating steroid avoidance and low-dose calcineurin inhibitor with ATG induction in renal transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Vastra Gotaland Region | Conditions: Diabetes Mellitus | Phase 4 | Status: COMPLETED